Despite the stigma, THC can be a powerful ally in therapy when used with guidance and responsibility. In this interview, pharmacist Géssica Miranda demystifies the risks and shows how the right care transforms cannabis treatment into dignity and quality of life.

Neurotech International reported that it is currently working on an open-label Phase I and II clinical study in 20 children aged five to 17 years with Autism Spectrum Disorder (ASD)

Due to proposed amendments in the Chamber, the bill has returned to the Senate, which will analyze and potentially approve the changes

The industry stands out for its high standards in processes to integrate into the pharmaceutical supply chain, including Good Manufacturing Practices, with elevated and nationwide certifications.

Many users believe that a regular dose of CBD helps improve focus and motivation, making it easier to overcome the workload

A scientific review highlights the lack of robust evidence on medical cannabis and reinforces the need for more rigorous and balanced research in the field

Practical guide teaches how to identify robust studies, recognize biases, and understand the hierarchy of evidence in the medical cannabis sector

While PubMed registers record publications, JAMA review questions the robustness of evidence; understand the current scenario of cannabis research

Survey in the United Kingdom indicates that the majority of patients undergoing medical cannabis treatment report significant improvement in quality of life and daily activities

Initiative creates unprecedented database to analyze the quality of oils from patient associations and boost clinical trials in Brazil

Initiative creates unprecedented database to analyze the quality of oils from patient associations and boost clinical trials in Brazil

Institutions like UEL and UEM strengthen scientific research and dialogue with society to demystify the therapeutic use of the plant and influence public policies

New technique uses centrifugal partition chromatography and achieves 85% CBD in a product with only 0.02% THC

Report featuring Brazilian participation highlights successful clinical cases

Initiative brings together universities to boost research and innovation in the field of medicinal cannabis in the country

Study identifies cannabielsoxa, a new cannabinoid from marijuana, and points out that other compounds from the plant may inhibit neuroblastoma cells, a type of cancer that primarily affects children.

Groundbreaking research proves effectiveness and precision of the 'Herbalist Method' and reinforces the role of associations in the scientific development of Brazil

The development of the medicinal and industrial sector of cannabis through science and regulation

The first study is being conducted in partnership with an association in Santa Maria, Rio Grande do Sul

Even though the tests were conducted on only one patient, the study showed that a THC-rich cannabis extract can reverse much of the damage caused by the disease